Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2020-04-01 History
Report ID 79218
Drug Identification Number 02240286
Brand name MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10x1mLV
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-02-04
Estimated end date Unknown
Actual end date 2019-03-02
Shortage status Resolved
Updated date 2020-04-01
Company comments Competitive BO resulting in limited supply. Closely monitoring stock at wholesalers.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-04-01 French Compare
v6 2020-04-01 English Compare
v5 2020-04-01 English Compare
v4 2019-05-07 French Compare
v3 2019-05-07 English Compare
v2 2019-03-22 French Compare
v1 2019-03-22 English Compare

Showing 1 to 7 of 7